Profile
Full Name
Rocket Pharmaceuticals, Inc.Ticker Symbol
RCKTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 18, 2015Indexes
Not includedWebsite
http://www.rocketpharma.comEmployees
299Key Details
Price
$6.15(-5.82%)
Market cap
$655.77M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.73(+6.51% YoY)
PE ratio
-
Next earnings date
May 6, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Rocket Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Needham
BuyMar 12, 25 BMO Capital
OutperformMar 3, 25 Scotiabank
Sector OutperformMar 3, 25 Goldman Sachs
NeutralMar 3, 25 Canaccord Genuity
BuyFeb 28, 25 Needham
BuyFeb 28, 25 Chardan Capital
BuyDec 18, 24 Jefferies
BuyNov 19, 24 Needham
BuyNov 19, 24 Leerink Partners
OutperformInstitutional Ownership
- What is the ticker symbol for Rocket Pharmaceuticals?
- Does Rocket Pharmaceuticals pay dividends?
- What sector is Rocket Pharmaceuticals in?
- What industry is Rocket Pharmaceuticals in?
- What country is Rocket Pharmaceuticals based in?
- When did Rocket Pharmaceuticals go public?
- Is Rocket Pharmaceuticals in the S&P 500?
- Is Rocket Pharmaceuticals in the NASDAQ 100?
- Is Rocket Pharmaceuticals in the Dow Jones?
- When was Rocket Pharmaceuticals's last earnings report?
- When does Rocket Pharmaceuticals report earnings?
- Should I buy Rocket Pharmaceuticals stock now?
What is the ticker symbol for Rocket Pharmaceuticals?
The ticker symbol for Rocket Pharmaceuticals is NASDAQ:RCKT
Does Rocket Pharmaceuticals pay dividends?
No, Rocket Pharmaceuticals does not pay dividends
What sector is Rocket Pharmaceuticals in?
Rocket Pharmaceuticals is in the Healthcare sector
What industry is Rocket Pharmaceuticals in?
Rocket Pharmaceuticals is in the Biotechnology industry
What country is Rocket Pharmaceuticals based in?
Rocket Pharmaceuticals is headquartered in United States
When did Rocket Pharmaceuticals go public?
Rocket Pharmaceuticals's initial public offering (IPO) was on February 18, 2015
Is Rocket Pharmaceuticals in the S&P 500?
No, Rocket Pharmaceuticals is not included in the S&P 500 index
Is Rocket Pharmaceuticals in the NASDAQ 100?
No, Rocket Pharmaceuticals is not included in the NASDAQ 100 index
Is Rocket Pharmaceuticals in the Dow Jones?
No, Rocket Pharmaceuticals is not included in the Dow Jones index
When was Rocket Pharmaceuticals's last earnings report?
Rocket Pharmaceuticals's most recent earnings report was on Feb 27, 2025
When does Rocket Pharmaceuticals report earnings?
The next expected earnings date for Rocket Pharmaceuticals is May 6, 2025
Should I buy Rocket Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions